Abstract

BackgroundIdentifying gastric heterotopic pancreas and stromal tumors is difficult. Few studies have reported computed tomography (CT) findings for differentiating lesions less than 3 cm in diameter. In this study, we aimed to identify clinical characteristics and CT findings that can differentiate gastric heterotopic pancreatic lesions from stromal tumors less than 3 cm in diameter.MethodsA total of 132 patients with pathologically confirmed gastric heterotopic pancreas (n = 66) and stromal tumors (n = 66) were included. Each group was divided into primary (n = 50) and validation cohort (n = 16). Clinical characteristics and CT findings were retrospectively reviewed. CT findings included location, border, contour, growth pattern, enhancement pattern and grade, the enhancement value of tumor, enhancement ratio of tumor, and enhancement ratio of tumor to pancreas in venous phase. The findings in the two groups were compared using the Pearson χ2 test or Student t-test. Receiver operating characteristic curves were used to determine areas under the curve and optimal cut-offs.ResultsSignificant differences were observed between heterotopic pancreas and stromal tumors in the distribution of tumor location, border, contour (all P < 0.001), enhancement values (P < 0.001), enhancement ratios of tumors (P < 0.001), and enhancement ratios of tumors to pancreas (P < 0.001). No significant differences existed in growth pattern (P = 0.203). The area under the curve differed significantly between enhancement ratio of tumor to pancreas and enhancement ratio (P = 0.030). There were significant differences in above characteristics between two groups in validation cohort.ConclusionsHeterotopic pancreas has characteristic CT features differentiating it from stromal tumors.

Highlights

  • Identifying gastric heterotopic pancreas and stromal tumors is difficult

  • 10–15 per million people worldwide are diagnosed with gastrointestinal stromal tumors (STs) each year, with most of these tumors located in the stomach [3]

  • A total of 189 patients met the inclusion criteria; numbers differed between the two groups, and the same numbers of STs were selected according to stratified random sampling method, based on the yearly distribution of Heterotopic pancreatic (HP) masses

Read more

Summary

Introduction

Identifying gastric heterotopic pancreas and stromal tumors is difficult. Few studies have reported computed tomography (CT) findings for differentiating lesions less than 3 cm in diameter. We aimed to identify clinical characteristics and CT findings that can differentiate gastric heterotopic pancreatic lesions from stromal tumors less than 3 cm in diameter. Heterotopic pancreatic (HP) masses and stromal tumors (STs) are common gastric submucosa tumors. 10–15 per million people worldwide are diagnosed with gastrointestinal STs each year, with most of these tumors located in the stomach [3]. Both the management and prognosis of these two tumors are different [4,5,6]. Gastroscopic biopsy is regarded as the gold standard for the diagnosis of tumors, limitations include its invasive

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call